Michael Sandler, OD
Optometrist · Delray Beach, FLNPI 1023093010
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $613, 3.8 times the $162 reported in 2019.
Across 18 payments — averaging $62.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$262
- Johnson & Johnson Vision Care, Inc.$261
- Bausch & Lomb Americas Inc.$151
- NEW World Medical,inc.$123
- Maculogix, Inc.$110
- Alcon$72
- plus $147 from 4 others
Across 17 payments — averaging $1437.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$24K
What the payments were for
- Consulting fees$404%
- Food & beverage$1,08696%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 2 | $262 |
| Johnson & Johnson Vision Care, Inc. | 7 | $261 |
| Bausch & Lomb Americas Inc. | 2 | $151 |
| NEW World Medical,inc. | 1 | $123 |
| Maculogix, Inc. | 1 | $110 |
| Alcon | 1 | $72 |
| Rxsight Inc | 1 | $62 |
| Shire North American Group Inc | 1 | $40 |
| Coopervision Inc. | 1 | $32 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Photrexa Viscous and Photrexa$262
- MIEBO$125
- XIIDRA$125
- AdaptDx$110
How this compares
$1,126 in reported general payments places this provider in the 55th percentile of 3,166 optometrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 39 | $527 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Delray Beach
- James HoffmanOrange Park$795K
- April JasperWest Palm Beach$553K
- Nora CothranLargo$505K
- Michael SluskyNorth Port$384K
- Katie SpearDefuniak Springs$361K
- Karen HoffmanOrange Park$282K
- Ashley RothMiami Beach$261K
- Jessica SteenDavie$256K
- Mark DunbarMiami$236K
- Robert DavisPembroke Pines$217K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.